The use of antihistamines in safety-critical jobs: A meeting report

Current Medical Research and Opinion

Volumn 18, Issue 6, 2002, Pages 332-337

  Mohler, Stanley R ^a   Nicholson, Anthony ^a   Harvey, Phillip ^a   Miura, Yasuhiko ^a   Meeves, Suzanne G ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Aircrew; Antihistamines; Fexofenadine; Histamine H1 receptor antagonists; Impairment; Pilots; Safety critical jobs; Sedation

Indexed keywords

ANTIHISTAMINIC AGENT; DIPHENHYDRAMINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; PROMETHAZINE;

AEROSPACE MEDICINE; AIRPLANE CREW; AIRPLANE PILOT; ALLERGIC RHINITIS; CLINICAL TRIAL; DROWSINESS; DRUG SAFETY; DRUG UTILIZATION; HUMAN; LABORATORY TEST; REVIEW; SEDATION; VALIDATION PROCESS;

AVIATION; COGNITION; HISTAMINE H1 ANTAGONISTS; HUMANS; OCCUPATIONAL DISEASES; OCCUPATIONS; RHINITIS, ALLERGIC, SEASONAL; SAFETY; SEASONS; SLEEP STAGES; TERFENADINE;

EID: 0036427456     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125000877     Document Type: Review

References (25)

1. Hindmarch I, Shamsi Z. Antihistamines: Models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin Exp Allergy 1999;29(3):133-42
2. Shamsi Z, Hindmarch I. Sedation and antihistamines: A review of inter-drug difference using proportional impairment ratios. Hum Psychopharmacol Clin Expl 2000;15:S3-S30
3. Mann R, Pearce G, Dunn N, Shakir S. Sedation with 'non-sedating' antihistamines: Four prescription-event monitoring studies in general practice. BMJ 2000;320:1184-7
4. Van Cauwenberge P, Bachert C, Passalaqua G, et al. Consensus statement on the treatment of allergic rhinitis. Allergy 2000;55:116-34
5. Bronsky EA, Falliers CJ, Kaiser HB, et al. Effectiveness and safety of fexofenadine, a new nonsedating H1 receptor antagonist, in the treatment of fall allergies. Allergy Asthma Proc 1998;19(3):135-41
6. Bernstein DI, Schoenwetter WF, Nathan RA, et al. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997;79:443-8
7. Bedard PM, Del Carpio J, Drouin MA, et al. Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis. Clin Ther 1992:14(2):268-75
8. Russell T, Stoltz M, Weir S. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers. Clin Pharmacol Ther 1998;64(6):612-21
9. Hindmarch I, Shamsi Z, Stanley N, Fairweather DB. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. Br J Clin Pharmacol 1999;48:200-06
10. Bower E, Moore J, Moss M, et al. Effects of single-dose fexofenadine 180 mg, diphenhydramine 50 mg, and placebo on cognitive and psychomotor performance in naval flight personnel in a double-blind, crossover, randomized study [Abstract]. Aviat Space Environ Med 2001;72(3):289
11. Gengo FM, Manning C. A review of the effects of antihistamines on mental processes related to automobile driving. J Allergy Clin Immunol 1990;86(6 Pt 2):1034-9
12. Vuurman EF, Uiterwijk MM, Rosenzweig P, O'Hanlon JF. Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol 1994;47(3):253-9
13. Akerstedt T, Folkard S. The three-process model of alertness and its extension to performance, sleep latency, and sleep length. Chronobiol Int 1997;14(2):115-23
14. O'Donnell R. The NovaScan Test Paradigm: Theoretical Basis and Evaluation. Report. Nova Technology, Inc
15. Ortiz G. Effectiveness of PC-based flight simulation. Int J Aviat Psychol 1994;4(3):285-91
16. Nicholson AN, Turner C. Central effects of the H1 antihistamine, cetirizine. Aviat Space Environ Med 1998;69(2):166-71
17. Nicholson A, Stone BM, Turner C, Mills SL. Antihistamines and aircrew: usefulness of fexofenadine. Aviat Space Environ Med 2000;71(1):1-6
18. Report of the Human Factors and Medicine Panel Working Group 26. Medication for Military Aircrew: Current Use, Issues, and Strategies for Expanded Options. RTO Technical Report 14 (AC/323(HFM-014)TP/14). RTO/NATO 2001
19. Warren R, Simpson H, Hilchie J. Drugs detected in fatally injured drivers in the province of Ontario. In: Goldberg L (ed.), Alcohol, Drugs and Traffic Safety, Volume 1. Stockholm: Almquist and Wiksell 1981:203-17
20. Levocetirizine: Summary of Product Characteristics
21. Shamsi Z, Hindmarch I. Fexofenadine: Absence of effects on central nervous system function [Abstract P-595]. ACI International 2000 (Suppl 2);164
22. Hindmarch I, Shamsi Z. A double-blind, placebo controlled investigation of the effects of fexofenadine on objective assessment of cognitive abilities, psychomotor function and car driving skills [Abstract 515]. J Allergy Clin Immunol 2001;107(2):S156
23. Dogan A, Offord S, Catafau A, et al. Cerebral HI-receptor pattern at baseline and after a single oral dose of the antihistamine fexofenadine. Ann Allergy Asthma Immunol 2000;86(1):108(P71)
24. Vermeeren A, O'Hanlon JF. Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol 1998;101(3):306-11
25. Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med 2000;132(5):354-63